Increasing Incidence of Mucormycosis in University Hospital, Belgium

To determine why incidence of mucormycosis infections was increasing in a large university hospital in Belgium, we examined case data from 2000–2009. We found the increase was not related to voriconazole use but most probably to an increase in high-risk patients, particularly those with underlying h...

Full description

Bibliographic Details
Main Authors: Veroniek Saegeman, Johan Maertens, Wouter Meersseman, Isabel Spriet, Eric Verbeken, Katrien Lagrou
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2010-09-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/16/9/10-0276_article
_version_ 1828197928786722816
author Veroniek Saegeman
Johan Maertens
Wouter Meersseman
Isabel Spriet
Eric Verbeken
Katrien Lagrou
author_facet Veroniek Saegeman
Johan Maertens
Wouter Meersseman
Isabel Spriet
Eric Verbeken
Katrien Lagrou
author_sort Veroniek Saegeman
collection DOAJ
description To determine why incidence of mucormycosis infections was increasing in a large university hospital in Belgium, we examined case data from 2000–2009. We found the increase was not related to voriconazole use but most probably to an increase in high-risk patients, particularly those with underlying hematologic malignancies.
first_indexed 2024-04-12T10:28:52Z
format Article
id doaj.art-04666b89260e438685f87c745e7070fb
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-04-12T10:28:52Z
publishDate 2010-09-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-04666b89260e438685f87c745e7070fb2022-12-22T03:36:53ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592010-09-011691456145810.3201/eid1609.100276Increasing Incidence of Mucormycosis in University Hospital, BelgiumVeroniek SaegemanJohan MaertensWouter MeerssemanIsabel SprietEric VerbekenKatrien LagrouTo determine why incidence of mucormycosis infections was increasing in a large university hospital in Belgium, we examined case data from 2000–2009. We found the increase was not related to voriconazole use but most probably to an increase in high-risk patients, particularly those with underlying hematologic malignancies.https://wwwnc.cdc.gov/eid/article/16/9/10-0276_articleFungiinvasive fungal diseaseincidencevoriconazolehematologic neoplasmshematopoietic stem cell transplantation
spellingShingle Veroniek Saegeman
Johan Maertens
Wouter Meersseman
Isabel Spriet
Eric Verbeken
Katrien Lagrou
Increasing Incidence of Mucormycosis in University Hospital, Belgium
Emerging Infectious Diseases
Fungi
invasive fungal disease
incidence
voriconazole
hematologic neoplasms
hematopoietic stem cell transplantation
title Increasing Incidence of Mucormycosis in University Hospital, Belgium
title_full Increasing Incidence of Mucormycosis in University Hospital, Belgium
title_fullStr Increasing Incidence of Mucormycosis in University Hospital, Belgium
title_full_unstemmed Increasing Incidence of Mucormycosis in University Hospital, Belgium
title_short Increasing Incidence of Mucormycosis in University Hospital, Belgium
title_sort increasing incidence of mucormycosis in university hospital belgium
topic Fungi
invasive fungal disease
incidence
voriconazole
hematologic neoplasms
hematopoietic stem cell transplantation
url https://wwwnc.cdc.gov/eid/article/16/9/10-0276_article
work_keys_str_mv AT veronieksaegeman increasingincidenceofmucormycosisinuniversityhospitalbelgium
AT johanmaertens increasingincidenceofmucormycosisinuniversityhospitalbelgium
AT woutermeersseman increasingincidenceofmucormycosisinuniversityhospitalbelgium
AT isabelspriet increasingincidenceofmucormycosisinuniversityhospitalbelgium
AT ericverbeken increasingincidenceofmucormycosisinuniversityhospitalbelgium
AT katrienlagrou increasingincidenceofmucormycosisinuniversityhospitalbelgium